SALIOGEN THERAPEUTICS

saliogen-therapeutics-logo

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Its Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes they call Saliogase. With broad applicability, non-viral delivery capabilities of any size gene, and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond.

#SimilarOrganizations #People #Financial #Website #More

SALIOGEN THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Life Science Therapeutics

Founded:
2020-01-01

Address:
Burlington, Massachusetts, United States

Country:
United States

Website Url:
http://www.saliogen.com

Total Employee:
11+

Status:
Active

Contact:
(650) 906-9468

Total Funding:
135 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag


Similar Organizations

affinia-therapeutics-logo

Affinia Therapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

parthenon-therapeutics-logo

Parthenon Therapeutics

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

ray-therapeutics-logo

Ray Therapeutics

Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

sean-stalfort_image

Sean Stalfort Board Member @ SalioGen Therapeutics
Board_member

craig-gordon_image

Craig Gordon Board Member @ SalioGen Therapeutics
Board_member
2021-12-01

Current Employees Featured

not_available_image

Joseph Higgins
Joseph Higgins President & Chief Scientific Officer, Founder @ SalioGen Therapeutics
President & Chief Scientific Officer, Founder

sung-you_image

Sung You
Sung You Chief Business and Strategy Officer @ SalioGen Therapeutics
Chief Business and Strategy Officer
2021-07-01

ray-tabibiazar_image

Ray Tabibiazar
Ray Tabibiazar Chairman & CEO @ SalioGen Therapeutics
Chairman & CEO
2021-01-01

Founder


not_available_image

Joseph Higgins

Investors List

symbiosis-ii-llc_image

SymBiosis LLC

SymBiosis LLC investment in Series B - SalioGen Therapeutics

d1-capital-partners_image

D1 Capital Partners

D1 Capital Partners investment in Series B - SalioGen Therapeutics

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Series B - SalioGen Therapeutics

retinal-degeneration-fund_image

Retinal Degeneration Fund

Retinal Degeneration Fund investment in Series B - SalioGen Therapeutics

gordonmd-global-investments_image

GordonMD Global Investments

GordonMD Global Investments investment in Series B - SalioGen Therapeutics

the-cystic-fibrosis-foundation_image

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation investment in Series B - SalioGen Therapeutics

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Series B - SalioGen Therapeutics

epiq-capital-group_image

EPIQ Capital Group

EPIQ Capital Group investment in Series B - SalioGen Therapeutics

pbm-capital-group_image

PBM Capital Group

PBM Capital Group investment in Series A - SalioGen Therapeutics

Official Site Inspections

http://www.saliogen.com

  • Host name: 172.67.217.228
  • IP address: 172.67.217.228
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "SalioGen Therapeutics"

SalioGen Therapeutics - Crunchbase Company Profile …

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»

SalioGen Therapeutics - 2025 Company Profile - Tracxn

SalioGen Therapeutics is a series B company based in United States, founded in 2019 by Joseph J Higgins. It operates as a Provider of gene editing platform for cell and gene therapies for …See details»

SalioGen Therapeutics - Overview, News & Similar companies

View SalioGen Therapeutics (www.saliogen.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»

SalioGen Therapeutics Company Profile - Craft

SalioGen Therapeutics is a company developing genetic medicine for patients with inherited disorders. It uses a genetic modification approach that works by adding a new genomic code …See details»

SalioGen Therapeutics 2025 Company Profile: …

Information on valuation, funding, cap tables, investors, and executives for SalioGen Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Saliogen Therapeutics - Products, Competitors, Financials, …

About Saliogen Therapeutics Saliogen Therapeutics is a biotechnology company focused on advancing genetic medicine through its innovative Gene Coding technology. The company's …See details»

SalioGen Therapeutics Company Overview, Contact Details

Jan 5, 2022 SalioGen Therapeutics Biotechnology Research Massachusetts, United States 51-200 Employees SalioGen Therapeutics is a biotechnology company on a mission to accelerate …See details»

SalioGen Therapeutics

SalioGen Therapeutics Thank you for visiting the website for SalioGen Therapeutics (“Company”), a next-generation genetic medicine company formerly based in Lexington, MA. The Company is no longer operating. Any questions …See details»

Company: SalioGen Therapeutics - CRISPR Medicine

SalioGen Therapeutics is a biotechnology company that focuses on developing advanced gene therapy solutions. They specialise in a proprietary platform called Gene Coding™, which aims …See details»

SalioGen Therapeutics Company Profile | Management and

Find contact information for SalioGen Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and SalioGen Therapeutics's email format.See details»

SalioGen Therapeutics - VentureRadar

"SalioGen, The Gene Coding Company™, is advancing a new category of genetic medicine we call Gene Coding™. Gene Coding, a genetic modification approach, works by adding a new …See details»

SalioGen Therapeutics - workinbiotech.com

SalioGen Therapeutics is advancing potentially curative therapies using a new category of genetic medicines called Gene Coding. Gene Coding involves adding new genetic code to turn on, off …See details»

SalioGen Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap

Jun 15, 2025 Explore SalioGen Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 16 news, and 1 literature, Disease Domain:Nervous System Diseases, …See details»

SalioGen Therapeutics - News & Analysis - Crunchbase

Nov 11, 2024 SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»

SalioGen Therapeutics Overview | SignalHire Company Profile

SalioGen Therapeutics is a biotechnology company on a mission to accelerate the impact of genetic medicine for patients using its novel Gene Coding™ technology. Gene Coding is a non …See details»

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B ...

CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — SalioGen Therapeutics, a privately held biotechnology company developing Gene Coding™, a new category of genetic medicine, …See details»

SalioGen Therapeutics Strengthens its Leadership Team to

Jul 20, 2022 SalioGen Therapeutics has launched Gene Coding TM, a genetic medicine platform, to develop durable, broadly applicable genetic medicines, using its Exact DNA …See details»

SalioGen Therapeutics - Funding, Financials, Valuation & Investors

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»

SalioGen - SymBiosis Capital Management

SalioGen Therapeutics has launched Gene CodingTM, a genetic medicine platform, to develop durable, broadly applicable genetic medicines, using its Exact DNA Integration Technology™ …See details»

SalioGen Therapeutics | LinkedIn

SalioGen Therapeutics | 2,093 followers on LinkedIn. Gene Therapy—Evolved. The Gene Coding Company. | SalioGen is advancing a new category of genetic medicine we call Gene Coding, …See details»

linkstock.net © 2022. All rights reserved